M. Park, J. Heo, Y. Kim, J. Han, D.-W. Kim, C. Lee, M. Cho, J. Park
{"title":"口服选择性脯氨酸- trna合成酶抑制剂DWN12088治疗特发性肺纤维化的安全性、耐受性和药代动力学/药效学评估","authors":"M. Park, J. Heo, Y. Kim, J. Han, D.-W. Kim, C. Lee, M. Cho, J. Park","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"46 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Safety, Tolerability and Pharmacokinetics/Pharmacodynamic Assessment of an Oral, Selective Prolyl-tRNA Synthetase Inhibitor, DWN12088, for the Treatment of Idiopathic Pulmonary Fibrosis in Healthy Subjects\",\"authors\":\"M. Park, J. Heo, Y. Kim, J. Han, D.-W. Kim, C. Lee, M. Cho, J. Park\",\"doi\":\"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":333033,\"journal\":{\"name\":\"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD\",\"volume\":\"46 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1897","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Safety, Tolerability and Pharmacokinetics/Pharmacodynamic Assessment of an Oral, Selective Prolyl-tRNA Synthetase Inhibitor, DWN12088, for the Treatment of Idiopathic Pulmonary Fibrosis in Healthy Subjects